Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal Anti-QSOX1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | QSOX1 antibody was raised against a 17 amino acid peptide near the center of human QSOX1. |
Rabbit Polyclonal Antibody against MAP2K1 (S217)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This MEK1(MAP2K1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 196-225 amino acids from human MEK1(MAP2K1). |
Rabbit Polyclonal MEK1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MEK1 |
Rabbit Polyclonal MEK1/2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MEK1/2 |
Rabbit Polyclonal MEK1/2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MEK1/2 |
Rabbit Polyclonal MEK1 (Thr291) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MEK1 around the phosphorylation site of Threonine 291 |
| Modifications | Phospho-specific |
Rabbit Polyclonal MEK1/2 (Ser217) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MEK1/2 around the phosphorylation site of Serine 217 |
| Modifications | Phospho-specific |
Rabbit Polyclonal MEK1/2 (Ser221) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MEK1/2 around the phosphorylation site of Serine 221 |
| Modifications | Phospho-specific |
Rabbit Anti-MEK1/2 (Ser218,222) Antibody (Phospho-Specific)
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser218/222 conjugated to KLH |
| Modifications | Phospho-specific |
Rabbit Polyclonal MEK1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat, Bovine, Canine, Chicken, Drosophila |
| Conjugation | Unconjugated |
| Immunogen | A portion of amino acids 200-250, containing phospho serine residues at positions 218 and 222, of human MEK1 was used as the immunogen. |
Rabbit anti Mek1 Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- MAP2K1
Reactivities
- Mouse
Filter by
Category
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Assay Types
Assay Platforms
Pathways
- Acute myeloid leukemia (224)
- B cell receptor signaling pathway (224)
- Bladder cancer (224)
- Chemokine signaling pathway (224)
- Chronic myeloid leukemia (224)
- Colorectal cancer (224)
- Dorso-ventral axis formation (224)
- Endometrial cancer (224)
- ErbB signaling pathway (224)
- Fc epsilon RI signaling pathway (224)
- Fc gamma R-mediated phagocytosis (224)
- Focal adhesion (224)
- Gap junction (224)
- Glioma (224)
- GnRH signaling pathway (224)
- Insulin signaling pathway (224)
- Long-term depression (224)
- Long-term potentiation (224)
- MAPK signaling pathway (224)
- Melanogenesis (224)
- Melanoma (224)
- Natural killer cell mediated cytotoxicity (224)
- Neurotrophin signaling pathway (224)
- Non-small cell lung cancer (224)
- Oocyte meiosis (224)
- Pancreatic cancer (224)
- Pathways in cancer (224)
- Prion diseases (224)
- Progesterone-mediated oocyte maturation (224)
- Prostate cancer (224)
- Regulation of actin cytoskeleton (224)
- Renal cell carcinoma (224)
- T cell receptor signaling pathway (224)
- Thyroid cancer (224)
- Toll-like receptor signaling pathway (224)
- VEGF signaling pathway (224)
- Vascular smooth muscle contraction (224)